Hummingbird’s Rational Antibody Discovery platform leverages data rich, systems biology approaches to identify critical functional regions of a target protein, drive production of antibodies against these epitopes, and then isolate the antibodies that bind to them, thereby optimizing the therapeutic potential of a target.
This systematic and rational approach overcomes many of the common challenges of antibody discovery and allows us to efficiently and precisely engineer next-generation therapies that uniquely hit the right targets for the right patients.
mAbHits is an immuno-engineering system to manipulate an immune response in order to control and optimize the production of antibodies against the desired optimal yet elusive epitopes. mAbHits results in a much higher proportion of usable therapeutic antibodies
mAbPredict uses computational biology to integrate and analyze data from multidisciplinary sources to produce validated insights into the biology of the disease and provide predictions regarding which epitopes should be targeted for optimal efficacy and safety profiles
Classical Approaches vs. Rational Antibody Discovery
Missing the Mark
Classical approaches to antibody discovery generally lead to the majority of antibodies produced missing the optimal epitopes
Optimal Yet Elusive Epitope
Hitting the Spot
Our Rational Antibody Discovery platform systematically identifies optimal target epitopes, and immuno-engineers an immune response that results in the majority of antibodies hitting the desired epitopes